Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Biomaterials ; 309: 122579, 2024 Sep.
Article in English | MEDLINE | ID: mdl-38670033

ABSTRACT

Owing to air pollution and the pandemic outbreak, the need for quantitative pulmonary monitoring has greatly increased. The COVID-19 outbreak has aroused attention for comfortable wireless monitoring of respiratory profiles and more real-time diagnosis of respiratory diseases. Although respiration sensors have been investigated extensively with single-pixel sensors, 2D respiration profiling with a pixelated array sensor has not been demonstrated for both exhaling and inhaling. Since the pixelated array sensor allowed for simultaneous profiling of the nasal breathing and oral breathing, it provides essential respiratory information such as breathing patterns, respiration habit, breathing disorders. In this study, we introduced an air-permeable, stretchable, and a pixelated pressure sensor that can be integrated into a commercial face mask. The mask sensor showed a strain-independent pressure-sensing performance, providing 2D pressure profiles for exhalation and inhalation. Real-time 2D respiration profiles could monitor various respiratory behaviors, such as oral/nasal breathing, clogged nose, out-of-breath, and coughing. Furthermore, they could detect respiratory diseases, such as rhinitis, sleep apnea, and pneumonia. The 2D respiratory profiling mask sensor is expected to be employed for remote respiration monitoring and timely patient treatment.


Subject(s)
COVID-19 , Masks , Respiration , SARS-CoV-2 , Humans , COVID-19/diagnosis , SARS-CoV-2/isolation & purification , Wireless Technology/instrumentation , Monitoring, Physiologic/instrumentation , Monitoring, Physiologic/methods , Equipment Design
2.
Small Methods ; 6(1): e2100869, 2022 01.
Article in English | MEDLINE | ID: mdl-35041271

ABSTRACT

Transparent multiscale 3D conformal electronics using hydroprinting with polyvinyl alcohol (PVA) as a sacrificial layer to transfer networks of silver nanowires (AgNWs) without a carrier layer is developed. However, AgNWs are known to disperse on water surfaces during the transfer process. Therefore, a functional film is developed by simultaneously welding and embedding AgNWs in the PVA through a simple one-step thermal pressing, demonstrating that ultrathin, transparent, and double-sided conductive/patterned nanomembranes with welded AgNWs can float on water without dispersion. The nanomembrane with an excellent figure of merit of 1200, a low sheet resistance of 16.2 Ω sq-1 , and a high transmittance of 98.17% achieves conformal contact with excellent step surface coverage of complex macro- and microstructures because of its nanoscale thickness (54.39 nm) and numerous deformable micro- and nanopores. Furthermore, the double-sided conductive nanomembranes facilitate wiring and layer-by-layer assembly, regardless of the transfer direction of the surface. As a proof-of-concept demonstration, a nanomembrane-based aneurysm sensor is developed. Its high transparency enables coil embolization, and the sensor can measure the pushing force of the coil within an aneurysm in an endovascular simulator. Moreover, this newly developed hydroprinting technology provides a new method for the fabrication of transparent multiscale 3D conformal electronics.

3.
Small Methods ; 5(12): e2101049, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34928033

ABSTRACT

Patterning of silver nanowires (AgNWs) used in fabricating flexible and transparent electrodes (FTEs) is essential for constructing a variety of optoelectronic devices. However, patterning AgNW electrodes using a simple, inexpensive, high-resolution, designable, and scalable process remains a challenge. Therefore, herein a novel solvent-free photolithographic technique using a UV-curable pressure sensitive adhesive (PSA) film for patterning AgNWs is introduced. The UV-curable PSA film can be selectively patterned by photopolymerization under UV exposure through a photomask. The AgNWs embedded in the non-photocured adhesive areas of the film are firmly held by a crosslinked network of photocurable resin when the patterned film is attached to the AgNW-coated substrate and additionally irradiated by UV light. After peeling off the film, the positive pattern of AgNW electrodes remains on the substrate, while the negative pattern is transferred to the film. This solvent-free photolithographic technique, which does not use toxic solvents, provides superior pattern features, such as fine line widths and spacings, sharp line edges, and low roughness. Therefore, the developed technique could be successfully applied in the development of flexible and transparent optoelectronic devices, such as a self-cleaning electro-wetting-on-dielectric (EWOD) devices, transparent heaters, and FTEs.

4.
Radiat Res ; 195(2): 163-172, 2021 02 01.
Article in English | MEDLINE | ID: mdl-33316052

ABSTRACT

The interpretation of radiation dose is an important procedure for both radiological operators and persons who are exposed to background or artificial radiations. Dicentric chromosome assay (DCA) is one of the representative methods of dose estimation that discriminates the aberration in chromosomes modified by radiation. Despite the DCA-based automated radiation dose estimation methods proposed in previous studies, there are still limitations to the accuracy of dose estimation. In this study, a DCA-based automated dose estimation system using deep learning methods is proposed. The system is comprised of three stages. In the first stage, a classifier based on a deep learning technique is used for filtering the chromosome images that are not appropriate for use in distinguishing the chromosome; 99% filtering accuracy was achieved with 2,040 test images. In the second stage, the dicentric rate is evaluated by counting and identifying chromosomes based on the Feature Pyramid Network, which is one of the object detection algorithms based on deep learning architecture. The accuracies of the neural networks for counting and identifying chromosomes were estimated at over 97% and 90%, respectively. In the third stage, dose estimation is conducted using the dicentric rate and the dose-response curve. The accuracies of the system were estimated using two independent samples; absorbed doses ranging from 1- 4 Gy agreed well within a 99% confidential interval showing highest accuracy compared to those in previous studies. The goal of this study was to provide insights towards achieving complete automation of the radiation dose estimation, especially in the event of a large-scale radiation exposure incident.


Subject(s)
Chromosome Aberrations/radiation effects , Chromosomes, Human/radiation effects , Chromosomes/radiation effects , Deep Learning , Automation , Biological Assay , Chromosomes/genetics , Chromosomes, Human/genetics , Dose-Response Relationship, Radiation , Humans , Radiation Dosage , Radiation Exposure/adverse effects
5.
J Immunol ; 199(2): 643-655, 2017 07 15.
Article in English | MEDLINE | ID: mdl-28615417

ABSTRACT

Cryptococcus neoformans is a ubiquitous, opportunistic fungal pathogen but the cell signaling pathways that drive T cell responses regulating antifungal immunity are incompletely understood. Notch is a key signaling pathway regulating T cell development, and differentiation and functional responses of mature T cells in the periphery. The targeting of Notch signaling within T cells has been proposed as a potential treatment for alloimmune and autoimmune disorders, but it is unknown whether disturbances to T cell immunity may render these patients vulnerable to fungal infections. To elucidate the role of Notch signaling during fungal infections, we infected mice expressing the pan-Notch inhibitor dominant negative mastermind-like within mature T cells with C. neoformans Inhibition of T cell-restricted Notch signaling increased fungal burdens in the lungs and CNS, diminished pulmonary leukocyte recruitment, and simultaneously impaired Th1 and Th2 responses. Pulmonary leukocyte cultures from T cell Notch-deprived mice produced less IFN-γ, IL-5, and IL-13 than wild-type cells. This correlated with lower frequencies of IFN-γ-, IL-5-, and IL-13-producing CD4+ T cells, reduced expression of Th1 and Th2 associated transcription factors, Tbet and GATA3, and reduced production of IFN-γ by CD8+ T cells. In contrast, Th17 responses were largely unaffected by Notch signaling. The changes in T cell responses corresponded with impaired macrophage activation and reduced leukocyte accumulation, leading to diminished fungal control. These results identify Notch signaling as a previously unappreciated regulator of Th1 and Th2 immunity and an important element of antifungal defenses against cryptococcal infection and CNS dissemination.


Subject(s)
Cryptococcosis/immunology , Cryptococcus neoformans/immunology , Receptors, Notch/metabolism , Animals , Antigens, Fungal/immunology , CD4-Positive T-Lymphocytes/drug effects , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/drug effects , CD8-Positive T-Lymphocytes/immunology , Central Nervous System/parasitology , Cryptococcosis/microbiology , GATA3 Transcription Factor/metabolism , Interferon-gamma/biosynthesis , Interferon-gamma/immunology , Interleukin-13/biosynthesis , Interleukin-13/immunology , Interleukin-5/biosynthesis , Interleukin-5/immunology , Lung/parasitology , Macrophage Activation , Mice , Receptors, Notch/deficiency , Signal Transduction , Th1 Cells/immunology , Th17 Cells/immunology , Th2 Cells/immunology
6.
Genes Dev ; 28(21): 2407-20, 2014 Nov 01.
Article in English | MEDLINE | ID: mdl-25367036

ABSTRACT

Cerebellar development is regulated by a coordinated spatiotemporal interplay between granule neuron progenitors (GNPs), Purkinje neurons, and glia. Abnormal development can trigger motor deficits, and more recent data indicate important roles in aspects of memory, behavior, and autism spectrum disorders (ASDs). Germline mutation in the NF1 tumor suppressor gene underlies Neurofibromatosis type 1, a complex disease that enhances susceptibility to certain cancers and neurological disorders, including intellectual deficits and ASD. The NF1 gene encodes for neurofibromin, a RAS GTPase-activating protein, and thus negatively regulates the RAS signaling pathway. Here, using mouse models to direct conditional NF1 ablation in either embryonic cerebellar progenitors or neonatal GNPs, we show that neurofibromin is required for appropriate development of cerebellar folia layering and structure. Remarkably, neonatal administration of inhibitors of the ERK pathway reversed the morphological defects. Thus, our findings establish a critical cell-autonomous role for the NF1-RAS-ERK pathway in the appropriate regulation of cerebellar development and provide a basis for using neonatal ERK inhibitor-based therapies to treat NF1-induced cerebellar disorders.


Subject(s)
Cerebellum/embryology , MAP Kinase Signaling System/physiology , Neurofibromin 1/metabolism , Stem Cells/cytology , Stem Cells/physiology , ras Proteins/physiology , Animals , Cell Movement/genetics , Cell Proliferation/genetics , Cerebellum/cytology , Cerebellum/growth & development , Gene Deletion , Mice , Neurofibromin 1/genetics , Neurons/drug effects , Protein Kinase Inhibitors/pharmacology , Signal Transduction , Stem Cells/drug effects
7.
Autism Res ; 7(1): 60-71, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24408886

ABSTRACT

Fragile X syndrome (FXS) is the most common form of inherited mental retardation and the leading cause of autism. FXS is caused by mutation in a single gene, FMR1, which encodes an RNA-binding protein FMRP. FMRP is highly expressed in neurons and is hypothesized to have a role in synaptic structure, function, and plasticity by regulating mRNAs that encode pre- and post-synaptic proteins. Fmr1 knockout (KO) mice have been used as a model to study FXS. These mice have been reported to show a great degree of phenotypic variability based on the genetic background, environmental signals, and experimental methods. In this study, we sought to restrict FMRP deletion to two brain regions that have been implicated in FXS and autism. We show that ablating Fmr1 in differentiated neurons of hippocampus and cortex results in dendritic alterations and changes in synaptic marker intensity that are brain region specific. In our conditional mutant mice, FMRP-deleted neurons have activated AKT-mTOR pathway signaling in hippocampus but display no apparent behavioral phenotypes. These results highlight the importance of identifying additional factors that interact with Fmr1 to develop FXS.


Subject(s)
Cell Differentiation/genetics , Cerebral Cortex/metabolism , Cerebral Cortex/pathology , Chromosome Deletion , Fragile X Mental Retardation Protein/genetics , Hippocampus/metabolism , Hippocampus/pathology , Mitosis/genetics , Animals , Behavior, Animal/physiology , Dendrites/genetics , Dendrites/pathology , Fragile X Syndrome/genetics , Fragile X Syndrome/pathology , Mice , Mice, Knockout , Mice, Neurologic Mutants , Neurons/metabolism , Neurons/pathology , Phenotype , Proto-Oncogene Proteins c-akt/genetics , Reference Values , Signal Transduction/genetics , Synapses/genetics , Synapses/pathology , TOR Serine-Threonine Kinases/genetics
8.
Cell ; 152(5): 1077-90, 2013 Feb 28.
Article in English | MEDLINE | ID: mdl-23434321

ABSTRACT

Malignant peripheral nerve sheath tumors (MPNSTs) are soft tissue sarcomas that arise in connective tissue surrounding peripheral nerves. They occur sporadically in a subset of patients with neurofibromatosis type 1 (NF1). MPNSTs are highly aggressive, therapeutically resistant, and typically fatal. Using comparative transcriptome analysis, we identified CXCR4, a G-protein-coupled receptor, as highly expressed in mouse models of NF1-deficient MPNSTs, but not in nontransformed precursor cells. The chemokine receptor CXCR4 and its ligand, CXCL12, promote MPNST growth by stimulating cyclin D1 expression and cell-cycle progression through PI3-kinase (PI3K) and ß-catenin signaling. Suppression of CXCR4 activity either by shRNA or pharmacological inhibition decreases MPNST cell growth in culture and inhibits tumorigenesis in allografts and in spontaneous genetic mouse models of MPNST. We further demonstrate conservation of these activated molecular pathways in human MPNSTs. Our findings indicate a role for CXCR4 in NF1-associated MPNST development and identify a therapeutic target.


Subject(s)
Autocrine Communication , Chemokine CXCL12/metabolism , Nerve Sheath Neoplasms/metabolism , Nerve Sheath Neoplasms/pathology , Receptors, CXCR4/metabolism , Cell Cycle , Cell Proliferation , Cell Transformation, Neoplastic , Cells, Cultured , Gene Knockdown Techniques , Humans , Neurofibromatosis 1/metabolism , Phosphatidylinositol 3-Kinases/metabolism , Signal Transduction
9.
J Neurosci ; 32(17): 5880-90, 2012 Apr 25.
Article in English | MEDLINE | ID: mdl-22539849

ABSTRACT

Adult neurogenesis persists throughout life in restricted brain regions in mammals and is affected by various physiological and pathological conditions. The tumor suppressor gene Pten is involved in adult neurogenesis and is mutated in a subset of autism patients with macrocephaly; however, the link between the role of PTEN in adult neurogenesis and the etiology of autism has not been studied before. Moreover, the role of hippocampus, one of the brain regions where adult neurogenesis occurs, in development of autism is not clear. Here, we show that ablating Pten in adult neural stem cells in the subgranular zone of hippocampal dentate gyrus results in higher proliferation rate and accelerated differentiation of the stem/progenitor cells, leading to depletion of the neural stem cell pool and increased differentiation toward the astrocytic lineage at later stages. Pten-deleted stem/progenitor cells develop into hypertrophied neurons with abnormal polarity. Additionally, Pten mutant mice have macrocephaly and exhibit impairment in social interactions and seizure activity. Our data reveal a novel function for PTEN in adult hippocampal neurogenesis and indicate a role in the pathogenesis of abnormal social behaviors.


Subject(s)
Adult Stem Cells/physiology , Dentate Gyrus/cytology , Gene Expression Regulation/genetics , Neurogenesis/genetics , Neurons/physiology , PTEN Phosphohydrolase/deficiency , Adaptation, Ocular/genetics , Adult Stem Cells/drug effects , Age Factors , Animals , Bromodeoxyuridine/metabolism , Cell Differentiation/genetics , Cell Movement/genetics , Cells, Cultured , Dose-Response Relationship, Drug , Electroencephalography , Electromyography , Exploratory Behavior/physiology , Intercellular Signaling Peptides and Proteins/pharmacology , Intermediate Filament Proteins/genetics , Interpersonal Relations , Lateral Ventricles/cytology , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Memory/physiology , Mice , Mice, Inbred C57BL , Mice, Transgenic , Mutation/genetics , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Nestin , Neurogenesis/drug effects , Neurons/cytology , Propanolamines/metabolism , Proto-Oncogene Proteins c-akt/metabolism
10.
Hum Mol Genet ; 19(16): 3169-78, 2010 Aug 15.
Article in English | MEDLINE | ID: mdl-20538881

ABSTRACT

Glial fibrillary acidic protein (GFAP) is the major intermediate filament protein of astrocytes in the vertebrate central nervous system. Increased levels of GFAP are the hallmark feature of gliosis, a non-specific response of astrocytes to a wide variety of injuries and disorders of the CNS, and also occur in Alexander disease where the initial insult is a mutation within the coding region of GFAP itself. In both settings, excess GFAP may cause or exacerbate astrocyte dysfunction. With the goal of finding drugs that reduce the expression of GFAP, we have devised screens to detect changes in GFAP promoter activity or protein levels in primary cultures of mouse astrocytes in a 96-well format. We have applied these screens to libraries enriched in compounds that are already approved for human use by the FDA. We report that several compounds are active at micromolar levels in suppressing the expression of GFAP. Treatment of mice for 3 weeks with one of these drugs, clomipramine, causes nearly 50% reduction in the levels of GFAP protein in brain.


Subject(s)
Astrocytes/drug effects , Astrocytes/metabolism , Glial Fibrillary Acidic Protein/antagonists & inhibitors , Glial Fibrillary Acidic Protein/metabolism , Amitriptyline/pharmacology , Animals , Animals, Newborn , Antidepressive Agents, Tricyclic/pharmacology , Astrocytes/cytology , Cells, Cultured , Clomipramine/pharmacology , Dose-Response Relationship, Drug , Drug Evaluation, Preclinical , Enzyme-Linked Immunosorbent Assay , Glial Fibrillary Acidic Protein/genetics , Humans , Luciferases/genetics , Luciferases/metabolism , Mice , Mice, Transgenic , Microscopy, Fluorescence , Promoter Regions, Genetic/genetics , Time Factors
11.
Immunol Cell Biol ; 88(2): 197-204, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19935767

ABSTRACT

This study examined the hypothesis that the control of NADPH oxidase-2 (Nox2)-mediated reactive oxygen species (ROS) regulates the expression of matrix metalloproteinases (MMPs) and the migration of macrophages. Lipopolysaccharide (LPS) stimulation of Raw264.7 cells and mice peritoneal macrophages increased the expression of MMP-9, 10, 12 and 13 mRNA, and also increased Raw264.7 cell migration. Treatment with an antioxidant (N-acetyl cysteine) or Nox inhibitors strongly inhibited the expression of MMPs by LPS and inhibited cell migration. LPS caused ROS production in macrophages and increased the mRNA expression of Nox isoforms Nox1 and Nox2 by 20-fold and two-fold, respectively. While Nox1 small interfering RNA (siRNA) did not inhibit LPS-mediated expression of MMPs, Nox2 siRNA inhibited the expressions of MMP-9, 10 and 12. Neither Nox1 nor Nox2 siRNA influenced the LPS-mediated expression of MMP-13. In addition, NAC or apocynin attenuated LPS-induced ROS production and MMP-9 expression. MMP-9 expression and cell migration were controlled by ERK1/2-ROS signaling. Collectively, these results suggest that LPS stimulates ROS production via ERK and induce various types of MMPs expression and cell migration.


Subject(s)
Cell Movement/drug effects , Lipopolysaccharides/pharmacology , Macrophages/cytology , Macrophages/enzymology , Matrix Metalloproteinases/genetics , Membrane Glycoproteins/metabolism , NADPH Oxidases/metabolism , Animals , Antioxidants/pharmacology , Cell Line , Extracellular Signal-Regulated MAP Kinases/metabolism , Gene Expression Regulation, Enzymologic/drug effects , Macrophages/drug effects , Matrix Metalloproteinases/metabolism , Membrane Glycoproteins/genetics , Mice , NADH, NADPH Oxidoreductases/genetics , NADH, NADPH Oxidoreductases/metabolism , NADPH Oxidase 1 , NADPH Oxidase 2 , NADPH Oxidases/genetics , RNA, Messenger/genetics , RNA, Messenger/metabolism , RNA, Small Interfering/metabolism
12.
J Neurochem ; 110(1): 343-51, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19457099

ABSTRACT

Glial fibrillary acidic protein (GFAP) is the major intermediate filament protein of astrocytes, and its expression changes dramatically during development and following injury. To facilitate study of the regulation of GFAP expression, we have generated dual transgenic mice expressing both firefly luciferase under the control of a 2.2 kb human GFAP promoter and Renilla luciferase under the control of a 0.5 kb human Glyceraldehyde 3 phosphate dehydrogenase (GAPDH) promoter for normalization of the GFAP signal. The GFAP-fLuc was highly expressed in brain compared to other tissues, and was limited to astrocytes, whereas the GAPDH-RLuc was more widely expressed. Normalization of the GFAP signal to the GAPDH signal reduced the inter-individual variability compared to using the GFAP signal alone. The GFAP/GAPDH ratio correctly reflected the up-regulation of GFAP that occurs following retinal degeneration in FVB/N mice because of the rd mutation. Following kainic acid-induced seizures, changes in the GFAP/GAPDH ratio precede those in total GFAP protein. In knock-in mice expressing the R236H Alexander disease mutant, GFAP promoter activity is only transiently elevated and may not entirely account for the accumulation of GFAP protein that takes place.


Subject(s)
Gene Expression Regulation/genetics , Genes, Reporter/genetics , Glial Fibrillary Acidic Protein/genetics , Luciferases/genetics , Molecular Biology/methods , Transgenes/genetics , Alexander Disease/genetics , Alexander Disease/metabolism , Animals , Biomarkers/analysis , Biomarkers/metabolism , Brain/metabolism , Drug Evaluation, Preclinical/methods , Epilepsy/genetics , Epilepsy/metabolism , Gene Knock-In Techniques , Glial Fibrillary Acidic Protein/metabolism , Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)/genetics , Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)/metabolism , Humans , Luciferases, Firefly/genetics , Luciferases, Renilla/genetics , Mice , Mice, Neurologic Mutants , Mice, Transgenic , Promoter Regions, Genetic/genetics , Retinal Degeneration/genetics , Retinal Degeneration/metabolism
13.
Exp Cell Res ; 315(7): 1260-72, 2009 Apr 15.
Article in English | MEDLINE | ID: mdl-19146851

ABSTRACT

Alexander disease is a fatal leukoencephalopathy caused by dominantly-acting coding mutations in GFAP. Previous work has also implicated elevations in absolute levels of GFAP as central to the pathogenesis of the disease. However, identification of the critical astrocyte functions that are compromised by mis-expression of GFAP has not yet been possible. To provide new tools for investigating the nature of astrocyte dysfunction in Alexander disease, we have established primary astrocyte cultures from two mouse models of Alexander disease, a transgenic that over-expresses wild type human GFAP, and a knock-in at the endogenous mouse locus that mimics a common Alexander disease mutation. We find that mutant GFAP, as well as excess wild type GFAP, promotes formation of cytoplasmic inclusions, disrupts the cytoskeleton, decreases cell proliferation, increases cell death, reduces proteasomal function, and compromises astrocyte resistance to stress.


Subject(s)
Astrocytes/physiology , Glial Fibrillary Acidic Protein/metabolism , Mice, Transgenic , Mutation , Alexander Disease/genetics , Alexander Disease/metabolism , Alexander Disease/pathology , Animals , Astrocytes/cytology , Caspases/metabolism , Cell Death/physiology , Cells, Cultured , Glial Fibrillary Acidic Protein/genetics , Humans , Hydrogen Peroxide/metabolism , Mice , Oxidants/metabolism , Oxidative Stress , Proteasome Endopeptidase Complex/metabolism , alpha-Crystallin B Chain/genetics , alpha-Crystallin B Chain/metabolism
14.
Hum Mol Genet ; 17(11): 1540-55, 2008 Jun 01.
Article in English | MEDLINE | ID: mdl-18276609

ABSTRACT

Glial fibrillary acidic protein (GFAP) is the principle intermediate filament (IF) protein in astrocytes. Mutations in the GFAP gene lead to Alexander disease (AxD), a rare, fatal neurological disorder characterized by the presence of abnormal astrocytes that contain GFAP protein aggregates, termed Rosenthal fibers (RFs), and the loss of myelin. All GFAP mutations cause the same histopathological defect, i.e. RFs, though little is known how the mutations affect protein accumulation as well as astrocyte function. In this study, we found that GFAP accumulation induces macroautophagy, a key clearance mechanism for prevention of aggregated proteins. This autophagic response is negatively regulated by mammalian target of rapamycin (mTOR). The activation of p38 MAPK by GFAP accumulation is in part responsible for the down-regulation of phosphorylated-mTOR and the subsequent activation of autophagy. Our study suggests that AxD mutant GFAP accumulation stimulates autophagy, in a manner regulated by p38 MAPK and mTOR signaling pathways. Autophagy, in turn, serves as a mechanism to reduce GFAP levels.


Subject(s)
Alexander Disease/genetics , Alexander Disease/metabolism , Autophagy/genetics , Glial Fibrillary Acidic Protein/genetics , Glial Fibrillary Acidic Protein/metabolism , Protein Kinases/metabolism , p38 Mitogen-Activated Protein Kinases/metabolism , Animals , Astrocytes/metabolism , Brain/metabolism , Brain/ultrastructure , Cell Line, Tumor , Humans , Mice , Mice, Mutant Strains , Mutation , Protein Kinase Inhibitors , Protein Kinases/genetics , RNA, Small Interfering/genetics , Signal Transduction , TOR Serine-Threonine Kinases , Vacuoles/metabolism , p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors , p38 Mitogen-Activated Protein Kinases/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...